title: [Withdrawal symptoms of ethanol are ameliorated by thymopentin in mice].
abstract: OBJECTIVE
  To explore the effect of thymopentin (TP5) on the choice of ethanol and ameliorating withdrawal symptoms (anxiety) of ethanol in mice.
  
  
  METHODS
  Mice were administered ethanol (v/v) in schedular fashion: 5% (1 week), 10% (1 week) and 15% (4 weeks), followed with the free choice between ethanol and water. Ethanol/(ethanol+water)x100% [E/(E+W)x100%] was measured as an index of ethanol selection. Light-dark box test and elevated plus maze test were chosen for the assessment of anxiety pre-drug and post-drug. After TP5 [0.2 mg/(kgxd), 0.4 mg/(kgxd)], i.p. or saline (vehicle control), i.p. for 14 days, the procedure was repeated.
  
  
  RESULTS
  (1) E/(E+W)x100%: the post-drug values of TP5 (0.2 mg/kg, 0.4 mg/kg) were lower significantly than the pre-drug values. (2) Light-dark box test: the post-drug values of number of entries and time spent in the light chamber of TP5 (0.2 mg/kg, 0.4 mg/kg) were more than the pre-drug values themselves and the post-drug value of saline. (3) Elevated plus maze test: the post-drug values of time spent on open arms of TP5 (0.2 mg/kg, 0.4 mg/kg) were more than the pre-drug values themselves and the post-drug value of salineìand the post-drug values of time spent on close arms of TP5 were less than the pre-drug values.
  
  
  CONCLUSIONS
  TP5 could decrease the uptake of ethanol and ameliorate anxious behavior associated with ethanol withdrawal in mice.
authors.affiliation: Department of Physiology and Pharmacology, School of Basic Medicine, Southeast University, Nanjing 210009, China.
authors.forename: Xue-lian
authors.initials: XL
authors.lastname: Han
authors.forename: Min
authors.initials: M
authors.lastname: Xu
authors.forename: De-yi
authors.initials: DY
authors.lastname: Xu
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D001007:Anxiety / Q000139:chemically induced / Q000517:prevention & control*; D000431:Ethanol / Q000008:administration & dosage / Q000633:toxicity*; D008297:Male; D051379:Mice; D011897:Random Allocation; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control* / Q000523:psychology; D016305:Thymopentin / Q000627:therapeutic use*
chemical_list: D000276:Adjuvants, Immunologic; D000431:Ethanol; D016305:Thymopentin